Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individuals.

Ninon Taylor; Ilse Schmid; Alexander Egle; Richard Greil; Wolfgang Patsch; Hannes Oberkofler

doi:10.3851/IMP1427

Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individuals.

Ninon Taylor (First author)
, Ilse Schmid
, Alexander Egle (Co-author)
, Richard Greil (Co-author)
, Wolfgang Patsch (Co-author)
, Hannes Oberkofler

Research output: Contribution to journal › Original Article › peer-review

12 Citations (Web of Science)

Original language	English
Pages (from-to)	118-193
Journal	ANTIVIRAL THERAPY
Volume	14
Issue number	8
DOIs	https://doi.org/10.3851/IMP1427
Publication status	Published - 2009

Keywords

TIME PCR ASSAY
ABBOTT REALTIME
AMPLICOR
QUANTIFICATION
MONITOR
RNA
DISCREPANCIES
SUBTYPES

Access to Document

10.3851/IMP1427

Cite this

@article{b6a31cec88114e64af7782c8d2010244,

title = "Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individuals.",

keywords = "TIME PCR ASSAY, ABBOTT REALTIME, AMPLICOR, QUANTIFICATION, MONITOR, RNA, DISCREPANCIES, SUBTYPES",

author = "Ninon Taylor and Ilse Schmid and Alexander Egle and Richard Greil and Wolfgang Patsch and Hannes Oberkofler",

year = "2009",

doi = "10.3851/IMP1427",

language = "English",

volume = "14",

pages = "118--193",

journal = "ANTIVIRAL THERAPY",

issn = "1359-6535",

publisher = "International Medical Press ",

number = "8",

}

TY - JOUR

T1 - Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individuals.

AU - Taylor, Ninon

AU - Schmid, Ilse

AU - Egle, Alexander

AU - Greil, Richard

AU - Patsch, Wolfgang

AU - Oberkofler, Hannes

PY - 2009

Y1 - 2009

KW - TIME PCR ASSAY

KW - ABBOTT REALTIME

KW - AMPLICOR

KW - QUANTIFICATION

KW - MONITOR

KW - RNA

KW - DISCREPANCIES

KW - SUBTYPES

U2 - 10.3851/IMP1427

DO - 10.3851/IMP1427

M3 - Original Article

C2 - 20032549

SN - 1359-6535

VL - 14

SP - 118

EP - 193

JO - ANTIVIRAL THERAPY

JF - ANTIVIRAL THERAPY

IS - 8

ER -